A. Elsherif, Y. Kodama, N. Uza, M. Hussein, M. Elhawary
{"title":"人平衡核苷转运蛋白1 (hENT1)和脱氧胞苷激酶(DCK)是胰腺癌切除术患者吉西他滨放化疗的预测性生物标志物:一项回顾性队列研究","authors":"A. Elsherif, Y. Kodama, N. Uza, M. Hussein, M. Elhawary","doi":"10.4103/azmj.azmj_59_22","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7711,"journal":{"name":"Al-Azhar Assiut Medical Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Human equilibrative nucleoside transporter 1 (hENT1) and deoxycytidine kinase (DCK) are predictive biomarkers for Gemcitabine-based chemoradiotherapy in resected pancreatic cancer patients: a retrospective cohort study\",\"authors\":\"A. Elsherif, Y. Kodama, N. Uza, M. Hussein, M. Elhawary\",\"doi\":\"10.4103/azmj.azmj_59_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7711,\"journal\":{\"name\":\"Al-Azhar Assiut Medical Journal\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Al-Azhar Assiut Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/azmj.azmj_59_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Al-Azhar Assiut Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/azmj.azmj_59_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Human equilibrative nucleoside transporter 1 (hENT1) and deoxycytidine kinase (DCK) are predictive biomarkers for Gemcitabine-based chemoradiotherapy in resected pancreatic cancer patients: a retrospective cohort study